Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Doerfler

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Lipid Research|October 28, 2020
Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductaseMarco De Giorgi, Kelsey E Jarrett, Jason C Burton, et al.
Molecular Therapy. Methods & Clinical Development|June 18, 2021
Targeting the <i>Apoa1</i> locus for liver-directed gene therapyMarco De Giorgi, Ang Li, Ayrea Hurley, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 23, 2020
Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) StudyMin Zhan, Rebecca M Doerfler, Dawei Xie, et al.
Atherosclerosis|June 8, 2023
High levels of lipoprotein(a) in transgenic mice exacerbate atherosclerosis and promote vulnerable plaque features in a sex-specific mannerJulia M Assini, Justin R Clark, Amer Youssef, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 11, 2017
Association of QT-Prolonging Medication Use in CKD with Electrocardiographic ManifestationsSoren Snitker, Rebecca M Doerfler, Elsayed Z Soliman, et al.
Molecular Therapy. Methods & Clinical Development|November 16, 2022
<i>LPA</i> disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept studyAlexandria M Doerfler, So Hyun Park, Julia M Assini, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 24, 2021
Risk of Potentially Inappropriate Medications in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) StudyRasheeda K Hall, Jacob B Blumenthal, Rebecca M Doerfler, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2022
Intestinal Deletion of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Promotes Expansion of the Resident Stem Cell CompartmentAlexandria M Doerfler, Jun Han, Kelsey E Jarrett, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 17, 2017
Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKDMin Zhan, Wendy L St Peter, Rebecca M Doerfler, et al.
Circulation. Cardiovascular Quality and Outcomes|June 27, 2020
Catheterization Laboratory Activation Time in Patients Transferred With ST-Segment-Elevation Myocardial Infarction: Insights From the Mission: Lifeline STEMI Accelerator-2 ProjectMichel Zeitouni, Hussein R Al-Khalidi, Mayme L Roettig, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Lipid Research|October 28, 2020
Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductaseMarco De Giorgi, Kelsey E Jarrett, Jason C Burton, et al.
Molecular Therapy. Methods & Clinical Development|June 18, 2021
Targeting the <i>Apoa1</i> locus for liver-directed gene therapyMarco De Giorgi, Ang Li, Ayrea Hurley, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 23, 2020
Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) StudyMin Zhan, Rebecca M Doerfler, Dawei Xie, et al.
Atherosclerosis|June 8, 2023
High levels of lipoprotein(a) in transgenic mice exacerbate atherosclerosis and promote vulnerable plaque features in a sex-specific mannerJulia M Assini, Justin R Clark, Amer Youssef, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 11, 2017
Association of QT-Prolonging Medication Use in CKD with Electrocardiographic ManifestationsSoren Snitker, Rebecca M Doerfler, Elsayed Z Soliman, et al.
Molecular Therapy. Methods & Clinical Development|November 16, 2022
<i>LPA</i> disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept studyAlexandria M Doerfler, So Hyun Park, Julia M Assini, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 24, 2021
Risk of Potentially Inappropriate Medications in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) StudyRasheeda K Hall, Jacob B Blumenthal, Rebecca M Doerfler, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2022
Intestinal Deletion of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Promotes Expansion of the Resident Stem Cell CompartmentAlexandria M Doerfler, Jun Han, Kelsey E Jarrett, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 17, 2017
Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKDMin Zhan, Wendy L St Peter, Rebecca M Doerfler, et al.
Circulation. Cardiovascular Quality and Outcomes|June 27, 2020
Catheterization Laboratory Activation Time in Patients Transferred With ST-Segment-Elevation Myocardial Infarction: Insights From the Mission: Lifeline STEMI Accelerator-2 ProjectMichel Zeitouni, Hussein R Al-Khalidi, Mayme L Roettig, et al.
Pageof 4